Cytosorbents CorporationCTSONASDAQ
Loading
Operating Income ScalingExpanding
Percentile Rank40
Studio
Year-over-Year Change

Profit from core business operations before interest and taxes

Latest
$-14.41M
↑ 22% vs avg
Percentile
P40
Within normal range
Streak
2 yr
Consecutive growthExpanding
Average
$-18.37M
Historical baseline
PeriodValueYoY Change
TTM$-14.41M+14.2%
2024$-16.79M+47.5%
2023$-31.95M-1.4%
2022$-31.52M-38.6%
2021$-22.74M-119.3%
2020$-10.37M+45.3%
2019$-18.97M-21.7%
2018$-15.58M-58.3%
2017$-9.84M+14.4%
2016$-11.49M-